|
Real-time Estimate
Cboe BZX
15:35:13 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 21.40 USD | -1.63% |
|
+2.01% | -19.02% |
| 09-22 | Oppenheimer Adjusts Price Target on Tyra Bioscience to $40 From $50, Keeps Outperform Rating | MT |
| 09-14 | Tyra Bioscience Shares Rise After Pricing $400 Million Offering | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.5B | - | - | - | - | - |
| 64.14B | |||||
| 55.53B | |||||
| 53.03B | |||||
| 45.99B | |||||
| 42.45B |
Select your edition
All financial news and data tailored to specific country editions
